VISN 15 A1C cprr testing, do-to to fund option period 4

Ended Awarded Last action

Contract number
36C25524N0274
Awardee
Awarding agency
Obligated
$238,305

Award facts

Contract value 100% obligated
$238,305.05 Current and potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
South San Francisco, CA 94080, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00008 -$44,331
Supplemental Agreement for work within scope P00007 -$25,663
Supplemental Agreement for work within scope P00006 -$600
Supplemental Agreement for work within scope P00005 $2,753
Supplemental Agreement for work within scope P00004 -$662
Supplemental Agreement for work within scope P00003 · VISN 15 A1C cprr testing, do-to MOD for option period 4. $129
Other Administrative Action P00002 · VISN 15 A1C cprr testing, no cost administrative do-to MOD for option period 4. $0
Other Administrative Action P00001 · VISN 15 A1C cprr testing, no cost administrative do-to MOD to revise PO numbers in descriptions of clins for option period 4. $0
Original award $306,679

About this award

Tosoh Bioscience, Inc. (doing business as Tosoh USA) received a modification to a Blanket Purchase Agreement call order from Veterans Integrated Service Network 15 (VISN 15) on June 1, 2024, to fund Option Period 4 of a contract for A1C (hemoglobin A1C) CPRR testing services. This firm fixed-price delivery order, valued at $238,305.05, is expected to be completed by September 30, 2025, and will be performed at the contractor's facility in South San Francisco, California. The award was made without a set-aside designation, allowing Tosoh Bioscience to compete as a full-sized commercial entity. This contract is supported by the Critical Analyzers, Laboratory (FSS-66-III) GSA Schedule, which enables task order issuance for specialized clinical diagnostic products.

Tosoh Bioscience is a global supplier of high-performance liquid chromatography (HPLC) testing products and specialized laboratory equipment with extensive experience providing HbA1c testing instrumentation, reagents, and clinical diagnostic supplies to the Department of Veterans Affairs. The company has secured numerous blanket purchase agreements and indefinite delivery vehicles across multiple VISNs, including contracts valued at over $2 million with VISN 16 and VISN 6, positioning it as a key provider of critical diabetes diagnostic capabilities within the federal healthcare system. This Option Period 4 modification represents a continuation of Tosoh's established relationship with the VA in supporting advanced laboratory testing services for veteran healthcare programs.

Quick answers

Who was awarded contract 36C25524N0274?

36C25524N0274 was awarded to Tosoh Bioscience, Inc. by Veterans Integrated Service Network 15 (Veterans Health Administration) on June 1, 2024.

How much is contract 36C25524N0274 worth?

The government has obligated $238,305 on 36C25524N0274.

Is contract 36C25524N0274 an order under another contract?

Yes. 36C25524N0274 is a BPA call under V797D40130-36C25520A0026, a blanket purchase agreement, on Critical Analyzers, Laboratory (FSS-66-III).

Was contract 36C25524N0274 competed?

The extent of competition for 36C25524N0274 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award